2023-509483-20-00招募中1 期
Investigating how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission Hub
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
招募中
3 期
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesDiabetes Mellitus, Type 2NCT07282613Novo Nordisk A/S80
招募中
3 期
A research study to look into the long-term effect on weight loss of CagriSema in people with obesityObesity2024-512144-39-00Novo Nordisk A/S160
招募中
4 期
The Impact of Semaglutide Compared to Energy Restriction on Type 2 DiabetesNCT07272343Second Affiliated Hospital of Nanchang University100
招募中
2 期
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal SyndromeHeart FailureAcute Kidney InjuryNCT07273838Yale University130
招募中
3 期
A research study looking at the effect of semaglutide on the immune system and other biological processes in people with Alzheimer's disease2023-506825-13-00Novo Nordisk A/S13